HFA
MBII

Hoover Financial Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Hoover Financial Advisors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$16K Buy
9,495
+6,495
+217% +$10.9K ﹤0.01% 426
2021
Q1 		$5K Hold
3,000
– – ﹤0.01% 499
2020
Q4 		$4K Buy
+3,000
New +$3.58K ﹤0.01% 479

Other funds holding MBII

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Hoover Financial Advisors's MBII Position: Q2 2021 in Review

Hoover Financial Advisors increased its Marrone Bio Innovations, Inc. (MBII) stake by 217% in Q2 2021, buying an estimated $10.9K and bringing the position to 9,495 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #426.

Hoover Financial Advisors first reported a position in MBII in Q4 2020 and has held it in 3 quarters since. 72 funds tracked by Wall St. Rank hold MBII as of Q2 2021.

  • Hoover Financial Advisors held 9,495 shares of Marrone Bio Innovations, Inc. worth $16K as of Q2 2021.
  • Hoover Financial Advisors bought 6,495 Marrone Bio Innovations, Inc. shares in Q2 2021, an estimated $10.9K.
  • Marrone Bio Innovations, Inc. made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #426 holding.
  • Hoover Financial Advisors first reported a position in Marrone Bio Innovations, Inc. in Q4 2020 and has held it in 3 quarters since.
  • 72 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.